article thumbnail

Goldman Sachs names five stocks with more upside following their latest earnings

CNBC: Investing

Other buy-rated names include: Tyson Foods, FMC, Match Group and Woodward. Tyson Foods The turnaround is underway at the poultry company, according to Goldman. In addition, beef is improving with "strength in chicken, pork, and prepared foods supporting the near-term," she added. The stock is 9% higher this month.

article thumbnail

Investing Principles: Lessons Learned from 20 Years of Wins, Losses, and Strikeouts

Mergers and Inquisitions

Allocations: If youre young, you should invest mostly in equities, but I believe gold and silver are often good replacements for fixed income in the traditional 80 / 20 or 60 / 40 portfolios. Investing Principles: Why a High Income Trumps Everything Else Between 2009 and 2014, I did not have a traditional portfolio via a brokerage firm.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

UBS gives 3 key AI stocks to own from here

CNBC: Investing

Markets Currencies Cryptocurrency Futures & Commodities Bonds Funds & ETFs Business Economy Finance Health & Science Media Real Estate Energy Climate Transportation Industrials Retail Wealth Sports Life Small Business Investing Personal Finance Fintech Financial Advisors Options Action ETF Street Buffett Archive Earnings Trader Talk Tech (..)

article thumbnail

Bank of America says these five stocks have more room to run

CNBC: Investing

The health foods category remains strong, she wrote, especially as consumer choose new and different ways to diet. Bellring Brands The energy drink and nutrition products company is firing on all cylinders, according to analyst Yasmine Deswandhy.

article thumbnail

PCE Welcomes Bradley Scharfenberg as Vice President, M&A

PCE

Contact Careers Client Login WHO WE ARE Show submenu for WHO WE ARE LEADERS TEAM CAREERS TRANSACTIONS FINANCIAL SOLUTIONS Show submenu for FINANCIAL SOLUTIONS MERGERS & ACQUISITIONS Show submenu for MERGERS & ACQUISITIONS Sell-side Buy-side Capital Raise Fairness Opinions EMPLOYEE OWNERSHIP Show submenu for EMPLOYEE OWNERSHIP ESOP Feasibility (..)

M&A
article thumbnail

Cooley’s 2024 Life Sciences M&A Year in Review: M&A Slims Down in 2024, but Will Appetites Grow in 2025?

Cooley M&A

Portfolio optimization through divestitures of noncore assets In addition to pharmas smaller appetite in 2024, pharma companies continued to slim down by shedding nonessential assets to sharpen their strategic focus on core products.

M&A
article thumbnail

Goldman profits jump 22% after investment banking gains

Financial Times - Banking

© THE FINANCIAL TIMES LTD 2025.